Rani Therapeutics Holdsing s (RANI) PT Lowered to $24 at BofA Securities
Tweet
Share
E-mailGet Alerts RANI Hot Sheet
Price: $0.80 --0%
Rating Summary:
12 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 9
Rating Summary:
12 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 9
Join SI Premium – FREE
BofA Securities analyst Geoff Meacham lowered the price target on Rani Therapeutics Holdsing s (NASDAQ: RANI) to $24.00 (from $28.00) while maintaining a Buy rating.
You May Also Be Interested In
- Berenberg Upgrades Accelleron Industries AG (ACLN:SW) to Buy
- KBC Group (KBC:BB) (KBCSY) PT Raised to EUR117 at Barclays
- Stroeer SE & Co KGaA (SAX:GR) PT Raised to EUR52 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
